These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702 [TBL] [Abstract][Full Text] [Related]
26. Air travel and pulmonary embolism: "economy class syndrome". Bhatia V; Arora P; Parida AK; Singh G; Kaul U Indian Heart J; 2008; 60(6):608-11. PubMed ID: 19276509 [TBL] [Abstract][Full Text] [Related]
27. Recurrence of venous thromboembolism after unfractionated heparin therapy. Kormas N; Manoharan A Ann Intern Med; 1996 Dec; 125(12):1012-3. PubMed ID: 8967700 [No Abstract] [Full Text] [Related]
28. Inflammatory bowel disease and thromboembolism. Is inflammation at the centre of the clot? O'Flynn AM; Watts M; Wall D; Molefe C; O'Keeffe D; Finucane P Ir Med J; 2013 Mar; 106(3):84-5. PubMed ID: 23951979 [TBL] [Abstract][Full Text] [Related]
29. New anticoagulants & clinical trials. Haideri N; Patel H Mo Med; 2009; 106(1):60-4. PubMed ID: 19245126 [TBL] [Abstract][Full Text] [Related]
30. Outpatient management of anticoagulation therapy. du Breuil AL; Umland EM Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618 [TBL] [Abstract][Full Text] [Related]
31. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822 [TBL] [Abstract][Full Text] [Related]
32. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
33. [Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. Verso M; Agnelli G Minerva Anestesiol; 1999; 65(1-2 Suppl 1):35-9. PubMed ID: 10206023 [No Abstract] [Full Text] [Related]
34. Advances in anticoagulation management: the role of pharmacy. Smythe MA Ann Pharmacother; 2007 Mar; 41(3):493-5. PubMed ID: 17341523 [No Abstract] [Full Text] [Related]
35. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Duhl AJ; Paidas MJ; Ural SH; Branch W; Casele H; Cox-Gill J; Hamersley SL; Hyers TM; Katz V; Kuhlmann R; Nutescu EA; Thorp JA; Zehnder JL; Am J Obstet Gynecol; 2007 Nov; 197(5):457.e1-21. PubMed ID: 17980177 [TBL] [Abstract][Full Text] [Related]
36. [Effect of heparin, aggregation inhibitors and vasoactive substances on chronic-obliterative vascular diseases]. Wenzel E; Nienhaus KH; Bahre G; Holzhüter H; Angelkort B; Meyer-Erkelenz Med Welt; 1976 Jun; 27(25):1242-7. PubMed ID: 933811 [No Abstract] [Full Text] [Related]
37. Left atrial appendage exclusion and the risk of thromboembolic events following mitral valve surgery. Almahameed ST; Khan M; Zuzek RW; Juratli N; Belden WA; Asher CR; Novaro GM; Martin DO; Natale A J Cardiovasc Electrophysiol; 2007 Apr; 18(4):364-6. PubMed ID: 17286567 [TBL] [Abstract][Full Text] [Related]
38. Chronic thromboembolic disease in a 43-year-old man. Savoia-McHugh LA; Menzies RD J Am Board Fam Pract; 2002; 15(4):313-5. PubMed ID: 12150466 [No Abstract] [Full Text] [Related]